Simplify Logo

Full-Time

Clinical Project Manager

Posted on 6/27/2024

Relay Therapeutics

Relay Therapeutics

201-500 employees

Biotech company focused on drug discovery

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Project Management
Business & Strategy
Required Skills
Communications
Public Speaking
Requirements
  • 5+ years of experience in clinical study management
  • Experience in oncology drug development
  • Strong knowledge of global regulatory and compliance requirements
  • Experience in CRO, vendor, and laboratory oversight
  • Excellent communication and public speaking skills
  • Strong interpersonal and organizational skills
Responsibilities
  • Overseeing day-to-day operations of study execution
  • Collaborating with cross-functional team to deliver clinical studies on time and within budget
  • Managing relationships with investigators, clinical site staff, and vendors
  • Developing and maintaining study documents
  • Ensuring effective vendor management
  • Reviewing monitoring reports and overseeing site visits
  • Coordinating with CROs on site selection and close-out planning
  • Preparing regulatory filings
  • Ensuring inspection readiness
  • Assisting with onboarding and mentoring new clinical operations associates

Relay Therapeutics focuses on drug discovery by emphasizing the movement of proteins in its research. The company uses its Dynamo™ platform, which integrates experimental and computational methods, to identify and develop new drugs, particularly for complex diseases that are hard to treat with traditional approaches. This platform enables Relay to target proteins that have previously been difficult to address, expanding treatment options, especially in precision oncology and genetic diseases. Unlike its competitors, Relay Therapeutics collaborates with major biotech firms, such as Genentech, to validate its technology and generate revenue through licensing and partnerships. The main goal of Relay Therapeutics is to create impactful medicines for patients, and it is actively conducting clinical trials to ensure the safety and effectiveness of its drug candidates.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

-10%

2 year growth

-2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Relay's focus on precision oncology and genetic diseases positions it at the forefront of personalized medicine, offering significant growth potential.
  • Recent investments and financing, including a $30 million private placement and $400 million Series C financing, indicate strong financial backing and investor confidence.
  • Initial clinical data for RLY-2608 and other promising drug candidates highlight the company's potential for successful therapeutic developments.

What critics are saying

  • The highly competitive biotech sector requires continuous innovation to maintain a leading position.
  • Dependence on strategic partnerships and licensing agreements could pose risks if collaborations do not yield expected results.

What makes Relay Therapeutics unique

  • Relay Therapeutics places protein motion at the core of its drug discovery process, a unique approach that sets it apart from traditional methods.
  • The Dynamo™ platform combines experimental and computational techniques to target previously undruggable proteins, expanding treatment possibilities.
  • Strategic collaborations, such as the one with Genentech, validate the potential of Relay's innovative technology and approach.

Benefits

Medical, dental, vision

Life, disability, & FSA

401k

Commuter benefits

Parental leave

Home office stipend

Tuition reimbursement

PTO

INACTIVE